Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Colonic Neoplasms × Bevacizumab × Clear all

Phase

Status

Completed 44 Terminated 21 Recruiting 9 Unknown 8 Withdrawn 6 Active not recruiting 6 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 27 Carcinoma, Hepatocellular 9 Ovarian Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Recurrence 4 Rectal Neoplasms 3 Neoplasm Metastasis 3 Glioblastoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Liver Neoplasms 2 Endometrial Neoplasms 2 mCRC 1 Uterine Cervical Neoplasms 1 Unresectable Metastatic Colorectal Cancer 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms Malignant 1 Proteinuria 1 Osteosarcoma 1 Non-small Cell Lung Cancer Patients with Brain Metastases 1 Neutropenia 1 Neoplastic Cells, Circulating 1 Neoplasms, Nerve Tissue 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Metastatic Colorectal Cancer With Left-sided Primary Tumor 1 Medulloblastoma 1 Lung Neoplasms 1

Interventions

Oxaliplatin 7 Fluorouracil 4 tislelizumab 3 Irinotecan 3 raltitrexed 2 pembrolizumab 2 Leucovorin 2 Chemotherapy, Adjuvant 2 Capecitabine 2 spartalizumab 1 sintilimab 1 rimegepant sulfate 1 encorafenib 1 cemiplimab 1 XELOX 1 Surgical Procedures, Operative 1 Radiofrequency Ablation 1 Preoperative Exercise 1 Neoadjuvant Therapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mortality 1 Laparoscopy 1 Immune Checkpoint Inhibitors 1 HMPL-013 1 HLX07 1 Genetic Testing 1 Everolimus 1 Drug Therapy 1 Diagnostic Tests, Routine 1 Conversion to Open Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07178717 2025-09-17

REFISH

Vall d'Hebron Institute of Oncology

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡